
Neurocognitive Disorders: New Developments and Therapies
A Randomized, Controlled Trial of a Central Nervous System-targeted ART STrategy for HIV-associated Neurocognitive Disorders
Ronald Ellis, MD, PhD
20th Conference on Retroviruses and Opportunistic Infections (CROI, February 2013)
(this will launch the CROI 2013 site, Dr. Ellis is presenter #2 at 15:44)
Presentations




